STUDIES ON INTERACTION OF MORIN WITH CURLI TO IDENTIFY AGGREGATION NATURE
Tirthankar Roy, Nisha Bhat, Shritoma SenguptaiD, Samudra Prosad BanikiD, Maitree BhattacharyyaiD, Pijush BasakiD
Abstract
Morin (3,5,7,2',4'-pentahydroxyflavone) is a flavonoid compound exhibited a range of biological functions, including anti-inflammatory, antioxidant, antiviral, and anti-allergic activities. It has the ability to disaggregate amyloid fibrils, making it a potential inhibitor of diseases caused by amyloid protein fibrillation. This study focuses on the interaction between Morin and Curli amyloid fibrils, which are produced by some Enterobacteriaceae, including Salmonella sp. And E. coli, as a major component of their biofilms. The Curli amyloid fibrils can lead to neurodegenerative diseases through a signalling cascade causing various human diseases, such as Alzheimers and Huntingtons diseases. Thioflavin T (ThT) fluorescence assays to purified Curli, and molecular docking between Morin and Curli indicates nature of binding at molecular level. The results showed that Morin quenched Curli fluorescence in a concentration-dependent manner, indicating dynamic quenching. Stern-Volmer analysis revealed that Morin binds to Curli with a binding constant of approximately 102 L/mol. This binding was found to be spontaneous, with hydrophobic interactions playing a significant role. ThT fluorescence assays confirmed that Morin inhibited Curli fibrillation, suggesting a potential therapeutic application. Molecular docking analysis revealed specific interactions between Morin and Curli, providing insights into their binding at the molecular level. In conclusion, this study demonstrates the dynamic quenching of Curli fluorescence by Morin and suggested that Morin may inhibit Curli fibrillation, making it a valuable candidate for the development of therapeutic drugs.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- S100A9 Inhibits and Redirects Prion Protein 89-230 Fragment Amyloid Aggregation
Mantas Ziaunys, Darius Sulskis, … Vytautas Smirnovas·bioRxiv·Feb 6, 2024
- Structural Insights into Curli CsgA Cross-β Fibril Architecture Inspired Repurposing of Anti-amyloid Compounds as Anti-biofilm Agents
- Interactions of curcumin's degradation products with the Aβ42 dimer: A computational study
Maryam Haji Dehabadi, Amedeo Caflisch, … Rohoullah Firouzi·The Journal of Physical Chemistry BPeer-reviewed·Sep 23, 2022
- Structural analysis of the bacterial amyloid curli
M. Sleutel, B. Pradhan, H. Remaut·bioRxiv·Feb 28, 2022
- The clinical drug candidate anle138b binds predominantly to the central cavity in lipidic Aβ fibrils and modulates fibril formation.
Mookyoung Han, Benedikt Frieg, … Christian Griesinger·bioRxiv·May 30, 2025
- Identifying interaction interface between Pseudomonas major biofilm forming functional amyloid FapC and disordered chaperone FapA during fibrillation deceleration
C.-H. Byeon, H. Saricayir, … U. Akbey·bioRxiv·Mar 14, 2023